2 June

Cancer patients who were on GLP-1 (the new ‘weight loss’) drugs had a 60% better survival rate. For some, even higher than that. Weight loss is just the tip of the iceberg of these drugs, as I post about frequently. They also have incredible anti-inflammatory effects, which is key to treating a vast range of disease. Plus much more. A senior doctor told me the current cost can put people and governments off. In his view subsidising them would save both the health system and people an absolute fortune. And the costs will plummet anyway, over time.